Chordia Therapeutics Inc. (TYO:190A)
Japan · Delayed Price · Currency is JPY 82.00
+3.00 (3.80%)
Jul 10, 2026, 3:30 PM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 6.34 billion as of July 10, 2026. Its market cap has decreased by -60.76% in one year.
Market Cap
6.34B
Enterprise Value
3.89B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
82.00
Market Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 6.34B, a decrease of -49.66%. That is a compound annual growth rate of -28.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 6.34B | -14.97% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
| Jun 14, 2024 | 12.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shinnihonseiyaku | 42.73B |
| Heartseed | 36.69B |
| YAKUODO HOLDINGS | 32.31B |
| Astena Holdings | 20.83B |
| Satudora Holdings | 17.23B |
| Ohki Healthcare Holdings | 16.03B |
| Medical System Network | 14.41B |
| Tsubota Laboratory | 6.45B |